SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Human & Experimental Toxicology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Hultén, B-A.
Right arrow Articles by Volans, G.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Hultén, B-A.
Right arrow Articles by Volans, G.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Activated Charcoal in Tricyclic Antidepressant Poisoning

B-Å. Hultén

Poisons Therapy Group, Department of Anaesthesia and Intensive Care, Sahlgren's Hospital, S-413 45 Gothenburg, Sweden

R. Adams

Accident and Emergency Department, Norfolk and Norwich Hospital, Brunswick Road, Norwich, UK

R. Askenasi

Emergency Department, Erasme Hospital, Brussels, Belgium

V. Dallos

Accident and Emergency Department, Whipps Cross Hospital, Leytonstone, London E11, UK

S. Dawling

National Poisons Unit, New Cross Hospital, London SE14 5ER, UK

A. Heath

Poisons Therapy Group, Department of Anaesthesia and Intensive Care, Sahlgren's Hospital, S-413 45 Gothenburg, Sweden

G. Volans

National Poisons Unit, New Cross Hospital, London SE14 5ER, UK

Tricyclic antidepressants (TCA) bind to activated charcoal both in vitro and in vivo in healthy volunteers after a therapeutic dose of TCA. These findings provide a basis for the routine use of activated charcoal in TCA poisoning. The object of this study was to examine the effect of a single dose of 20 g of activated charcoal in overdose patients. Ninety-one patients from four centres with suspected TCA overdose were entered into a randomized study. Gastric lavage was performed on all patients. Thirty-four received 20 g of activated charcoal and 43 served as controls. Fourteen patients were excluded. Plasma drug concentrations were taken on admission and at 1, 2, 4, 8 and 24 h. The incidence of toxic symptoms was registered during 24 h. There was no significant difference in the area under the plasma drug concentration versus time curve, the peak plasma concentrations or plasma half-lives between the two groups. Toxic symptoms were more frequent in the non-treated groups although this difference was not statistically significant. In patients with TCA overdose initially treated with gastric lavage, a single dose of 20 g of activated charcoal had no effect on the systemic absorption or elimination of TCA.

Human & Experimental Toxicology, Vol. 7, No. 4, 307-310 (1988)
DOI: 10.1177/096032718800700402


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement